Clinical trials · New York, NY
Hereditary Cancer Syndrome clinical trials in New York
We’re tracking 8 recruiting hereditary cancer syndrome studies with a site in or near New York — including Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near New York
- NCT05562778Recruiting
Chatbot helps you complete hereditary cancer genetic risk testing
This study tests whether a chatbot can help people complete hereditary cancer genetic risk assessment before a gynecology new-patient visit. It may help you understand and organize next steps for genetic testing, if needed.
New York, New YorkAges 18 years+ - NCT07052266Recruiting
Combined genetic screening for pregnancy and cancer risk
This trial offers a combined genetic test for both common inherited conditions and hereditary cancer risks to pregnant women or those planning pregnancy. It aims to see if adding cancer screening to routine pregnancy testing is helpful.
New York, New YorkAges 18–55 - NCT07195071Recruiting
Combining pregnancy carrier and cancer risk screening
This study combines routine obstetrical carrier screening with hereditary cancer risk screening in one blood draw. It aims to see if offering both tests together is feasible and helpful for patients receiving OB care.
New York, New YorkAges 18–55 - NCT06096688Recruiting
Finding new ways to lower colorectal and endometrial cancer risk
This study looks for new ways to lower the risk of colorectal and endometrial cancers. It collects tissue and information from people who are getting certain procedures or treatments at Weill Cornell Medicine.
New York, New YorkAges 18 years+ - NCT03922893Recruiting
Finding inherited cancer gene markers in at-risk families
This study looks at DNA (genetic information) from people and families who may have an inherited risk for cancer. It aims to find new genetic markers that can help explain cancer risk and guide future care.
New York, New YorkAges Any age - NCT02000089RecruitingPhase 3
Pancreas screening study for people at high cancer risk
This Phase 3 study tests a structured plan for checking the pancreas early in people with a higher-than-usual risk of pancreatic cancer. The goal is to find changes sooner, when treatment may be easier.
New York, New YorkAges 18 years+ - NCT04981509RecruitingPhase 2
Check if 3 medicines help advanced kidney cancer
This Phase 2 trial tests whether combining bevacizumab, erlotinib, and atezolizumab can shrink or control advanced kidney cancer. It’s aimed at people with certain kidney-cancer subtypes (including HLRCC-related cases or papillary kidney cancer) and who have not had many prior targeted or immune treatments.
New York, New YorkAges 12 years+ - NCT03250078Recruiting
Pancreatic cancer screening for people at high genetic risk
This study offers pancreatic cancer screening for people with strong family history or certain inherited gene changes. It may help find pancreatic cancer earlier, when treatment may be more effective.
Norwalk, ConnecticutAges 50–90
Hear when a new Hereditary Cancer Syndrome trial opens near New York, NY
We’ll email you when one opens near New York, NY — at most once a week, no account needed, unsubscribe anytime.
Where these studies are running near New York
Institutions with a site for the recruiting hereditary cancer syndrome studies listed above.
- Columbia University Irving Medical Center · 2 studies
- NYU Langone Health · 2 studies
- Weill Cornell Medicine · 2 studies
- Memorial Sloan Kettering Basking Ridge
- Memorial Sloan Kettering Bergen
- Memorial Sloan Kettering Cancer Center
- Memorial Sloan Kettering Cancer Center - Westchester
- Memorial Sloan Kettering Commack
What taking part in a hereditary cancer syndrome study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting hereditary cancer syndrome studies in New York.
Common questions
- Are there hereditary cancer syndrome clinical trials near New York?
- Yes. We're currently tracking 8 recruiting hereditary cancer syndrome studies with a site near New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a hereditary cancer syndrome study near New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site near New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a hereditary cancer syndrome trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New hereditary cancer syndrome studies open near New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.